An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a robust market exists on Telegram, where communities with numerous of participants share comparison images, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could lead to individuals injecting products of unknown origin.
Some experts said the popularity for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.
Service Response and Material Elimination
Based on TikTok, the platform has taken down violative content and banned associated keywords and query recommendations. The company said it was dedicated to keeping the service secure and investing in enhancing compliance measures.
Online Marketplace Operations
Investigations also found communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, populated with images of weight loss, positive reviews and detailed guides for preparing or injecting at home.
After moments of joining one group, a seller posted contact information, where most purchases take place. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, health issues or past usage.
Product Details and Pricing
Inside these groups, messages show dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service said it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they can’t verify. Although the science behind this drug is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the surge in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has previously seen individuals injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational product not yet authorized … may subject patients to potentially serious medical dangers”.
